PMP PALS AT SSO ADVANCED CANCER THERAPIES 2025

PMP PALS AT SSO ADVANCED CANCER THERAPIES 2025

Each year, PMP Pals sponsors the Society of Surgical Oncology/Advance Cancer Therapies conference (SSO/ACT) where specialists worldwide meet to discuss what’s new in peritoneal surface malignancies and related conditions. 

Find links to the SSO/ACT 2025 powerpoint presentations here:  https://s2.goeshow.com/sso/act/2025/final_program.cfm

Scroll down to Sunday’s Abstract Presentations: PSM Appendix and CRC Translational Science 

Here is a sample of what you will find on that page:

 Cernak_ACT_2025_PowerPoint.pptx
 ACT2025_WAGNER_Fusobacterium nucleatum tissue density.pptx
 ACT2025_WAGNER_Neutrophil Infiltration in the Peritoneal Tissue Microenvironment.pptx
 ACT2025_WAGNER_Neutrophil-related and Other Innate Immune Pathways.pptx
 ACT2025_WAGNER_Tumor-Associated Macrophage Subsets in Appendiceal Cancer.pptx
 Gironda_ACT_PTO_Heterogeneity_Presentation_02062025.pptx
 Apoptosis markers in HIPEC effluent_Nizri.pptx
 ACT PIK3CA.pptx
 ACT Presentation_v5.pptx

Board president Adele Jasion and board treasurer Charmaine Skillman pay their way to attend this event and connect with physicians on Pals’ behalf. Here’s Adele’s recap:  PMP Pals was represented at the Society of Surgical Oncology Advanced Cancer Therapies conference (SSO/ACT) on February 14-17. Charmaine and I had the privilege of connecting with our surgical oncology specialists, other medical professionals, researchers, our Medical Advisory Board, and our friends at the ACPMP Research Foundation. We showcased Pals’ dedication to providing support and resources to patients and caregivers affected by Appendix Cancer and its related conditions like Pseudomyxoma Peritonei (PMP). We raised awareness about the tireless work Pals does day in and day out to provide hope, education, support, fellowship, connections, and tools for building emotional resilience and dealing with the psychological challenges faced by PMP patients. The conference brought together opportunities to learn about clinical outcomes, current treatments, clinical trials, research, and other relevant topics as presented by some of the most brilliant minds in the medical community.

One conference highlight was the presentation of the 2025 Gabriella Graham Patient Advocate Award to Dr. Richard Alexander.Jr. from Rutgers Cancer Institute in New Jersey. We were thrilled to see Dr. Alexander recognized for his pioneering research and clinical work in advancing care and treatment for patients and for his heartfelt compassion and commitment to our patient community. Dr. Alexander truly exemplifies the spirit of the Gabriella Graham Patient Advocate Award and we are honored he accepted this year’s award honoring our beloved founder, Gabriella, a fierce advocate for patients who worked tirelessly to connect and inform patients, caregivers, and physicians. We have HOPE for you!  Adele Jasion, President, PMP Pals

Appendix Cancer on Radar: Making a Difference, Working Together

Appendix Cancer on Radar: Making a Difference, Working Together

Appendix Cancer on Radar: Making a Difference, Working Together

Amber is the official color of Appendix Cancer Awareness. It symbolizes the courage, strength, and resilience of appendix cancer patients, care partners, and their families. Working together, we aim to raise awareness among a wider community through shared messaging. Together we are stronger and louder…tog (ACPMP)ether we can make a difference!

PMP Pals, Appendix Cancer PMP Research Foundation (ACPMP), Pseudomyxoma Survivor, and CANCollaborate are united in enhancing understanding and support for patients with appendix cancer and the related condition pseudomyxoma peritonei. We’re advocating for more patient and care partner considerations, aggressive research to discover new treatments, and approval of existing, off-label uses. The goal? A cure, be it immunotherapy, chemotherapy cocktails, improved best practices, or early detection.

Join us this August as we come together to shine a light on appendix cancer and support those battling this rare and challenging disease. Here’s what you can do: